Top 50 Clinical Trial Platform - Pre Seed

Leapcure provides a platform that connects patients with clinical trials by utilizing patient advocacy and community engagement to enhance recruitment, engagement, and retention. The company addresses inefficiencies in clinical research by prioritizing patient experiences, saving over 1 million hours of research time across 42 countries.

OASYS NOW provides an AI-powered platform for clinical trial patient screening by transforming unstructured medical data like EHRs and referral letters into actionable patient cohorts. The service ensures compliance with EU data regulations through certified, privacy-by-design processes, significantly accelerating patient identification timelines. Key offerings include ELaiGIBLE for real-time eligibility screening and De-ID for secure pseudonymization of sensitive health information.

Miracle provides a unified dashboard that integrates data from various clinical trial platforms and vendors, enabling real-time analytics and visualization of recruitment and performance metrics. This technology helps clinical operations identify bottlenecks and enhance efficiency, allowing trials to be completed faster and with greater transparency.

UpTrials provides AI-powered tools to streamline clinical trial operations for sites, CROs, and sponsors. Their AI Trial Assistant automates workflows and simplifies protocols, while their Smart Staffing feature algorithmically matches organizations with pre-screened clinical research talent. This platform increases trial efficiency by reducing administrative burden, allowing teams to focus on patient care.

This startup provides an AI-driven platform that automates data standardization and error detection for clinical trials. It offers features like one-click SDTM conversion, intelligent error detection with real-time suggestions, and automatic queries to ensure data consistency and integrity for clinical practitioners and drug developers.

Baseline AI automates the generation of clinical trial documents and manages associated data through machine learning algorithms, significantly reducing the time and costs involved in trial administration. This technology addresses inefficiencies in document workflows and data handling, enabling faster and more accurate trial processes.

Menken provides eTMF and eISF platforms integrated with MenkenMONITOR, utilizing intelligent automation to enhance the management of clinical trial documentation and oversight. This technology reduces manual workload, minimizes errors, and improves data compliance, accelerating the overall trial process and ensuring timely delivery of life-saving treatments.

The startup offers a patient recruitment platform that connects clinical researchers with individuals seeking treatment options by providing detailed information on clinical trials, including eligibility criteria and study objectives. This platform addresses the challenge of patient enrollment in clinical studies, facilitating access to potential treatment opportunities for patients and enhancing recruitment efficiency for researchers.

Kenosha AI develops an artificial intelligence platform specifically for the clinical research industry, utilizing enterprise-grade AI to enhance operational efficiency and decision-making. The platform significantly reduces the time and resources required for tasks such as Informed Consent Form writing and regulatory inquiries, enabling faster clinical trial timelines and improved access to life-saving treatments.

Resync is a Provider Activation Platform that automates patient identification by leveraging electronic health record (EHR) data to pre-screen eligible participants for clinical trials. This technology reduces the burden on trial sites and providers, minimizing screening failures and improving enrollment accuracy.

Viata develops AI-powered solutions for clinical trial optimization and patient recruitment. The platform leverages machine learning to analyze complex genomic and clinical data, accelerating drug development timelines. This technology helps biopharma companies identify eligible patient cohorts faster and improve trial operational efficiency.

QuantHealth provides next-generation clinical AI for drug-patient simulations to guide clinical development decisions. The platform integrates biomedical, clinical, and epidemiological data into a unified framework for deep analysis. This enables optimization across clinical development, business development, and portfolio management use cases.

Amaros AI offers the AmarosEngine, a cloud‑native platform that aggregates ophthalmic EMR notes, imaging biomarkers, genomic data, and payer claims into a unified, queryable knowledge base. Its AI/ML models generate patient‑level risk scores, treatment response predictions, and real‑time trial eligibility matches, delivering insights via configurable dashboards and export tools for clinicians, CROs, and commercial teams.

The startup operates a network of clinical trial sites with embedded research centers specializing in allergy, dermatology, endocrinology, orthopedics, and ophthalmology. It focuses on large-volume recruitment of diverse and underserved patient populations, enabling clinical researchers to develop reliable therapies more efficiently.

Konsuld provides a HIPAA-compliant platform enabling clinicians to collaborate securely and access AI-generated clinical insights. The platform's AI is trained exclusively on rigorously vetted, peer-reviewed medical sources to support clinical reasoning at the point of care. This fusion of peer consultation and evidence-backed intelligence helps practitioners share cases and confirm treatment recommendations efficiently.

Solid IO develops precision oncology tools to personalize cancer treatment plans. Their platform analyzes patient-specific data to identify optimal therapies and predict treatment response, ultimately improving outcomes for cancer patients.

Dr.Evidence offers an AI‑powered platform that aggregates over 100 million regulatory, labeling, clinical trial, and scientific literature documents for biopharma teams. Its specialized machine‑learning and natural‑language models automate document search, extraction, and comparison, enabling faster regulatory submissions and strategic decision‑making. The solution also ensures zero IP leakage and enterprise‑grade security, delivering measurable ROI by reducing manual effort.

Evidose conducts effectiveness testing for supplements, functional foods, and cosmetics using rigorous clinical trial methodologies to ensure product efficacy. The company addresses the lack of reliable data in the market, providing measurable insights that enhance consumer trust and regulatory compliance.

Cove Neurosciences develops advanced brain data analytics pipelines to enhance the interpretation of neurological data, enabling researchers to derive clinically meaningful insights. Their platform accelerates neuroscience research and mitigates risks in clinical trials, ultimately improving treatment outcomes for brain-related disorders.

This company likely develops artificial intelligence solutions tailored for the healthcare sector. Their focus is on leveraging machine learning for applications such as diagnostics, patient management, or operational efficiency within medical systems. The core value proposition centers on integrating advanced AI technology to improve clinical outcomes and administrative processes in healthcare delivery.

StratifAI develops multimodal artificial intelligence models that extract prognostic insights from histology images and clinical data to inform treatment decisions in oncology. Their technology enables the identification of biomarkers and personalized treatment plans, reducing unnecessary chemotherapy and improving patient outcomes.

OmicsChart provides bioinformatics software and consulting services to accelerate drug development and life sciences research. The platform integrates diverse, real-world data sources, enabling unified analysis and biomarker discovery workflows. Expert support guides teams in extracting actionable insights from extensive, de-identified patient datasets.

This startup develops a data analytics platform that identifies existing non-cancer generic drugs with potential for cancer treatment. The platform synthesizes scientific and real-world data to discover and validate promising therapies for drug repurposing in oncology.

Knowtex provides Voice AI for clinical workflow automation, automatically generating documentation, orders, and referrals directly integrated with EMR systems. The platform surfaces clinical intelligence from conversations to support real-time decision-making, including trial eligibility and guideline searches. It also offers enterprise model evaluation tools ensuring transparency and auditable reliability for clinical AI applications.

Sable provides an AI-powered platform specifically designed for toxicologists to navigate drug target safety assessments. This platform unifies safety data from clinical, genetics, experimental, and literature sources to prioritize and mitigate toxicology risks. Users can make faster safety decisions by systematically evaluating comprehensive, up-to-date information.

This startup offers a cloud-based clinical pathway management platform that optimizes patient flow and clinical workflows across various healthcare specialties. By centralizing referral processes and streamlining preoperative assessments, the platform enhances operational efficiency and improves patient care delivery for over 200 healthcare organizations worldwide.

Ambit develops data-driven software platforms that identify and activate patients with rare diseases for biopharma companies. Their solutions enhance patient engagement and streamline the process of locating specialty patients, addressing the challenges of patient identification in commercial and pre-commercial settings.

The startup provides clinical trial staffing services that streamline resource management for research teams by recruiting qualified personnel from the life sciences sector. This enables clients to efficiently plan and execute clinical trials, ensuring they have the necessary talent to meet their research objectives.

Carelane provides an AI-powered, end-to-end platform specifically built for sponsors, CROs, and institutions conducting observational research and clinical trials. The platform digitizes protocol development using FHIR standards to accelerate study timelines and automate workflows from site selection to query management. This infrastructure significantly reduces the cost, complexity, and time associated with running patient registries, Phase IV trials, and academic research.

Ancora provides an AI-driven platform that matches cancer patients with relevant clinical trials based on their diagnosis, location, and preferences. Users can quickly search, refine results through a brief questionnaire, and track enrollment progress within a secure, HIPAA- and GDPR-compliant dashboard. The service is free, offering personalized trial alerts and the ability to share profiles with trial sites while maintaining strict privacy controls.

Themison is a patient-centric platform that utilizes real-time engagement analytics and a mobile app to enhance communication and support throughout clinical trials. By simplifying complex medical information and personalizing patient experiences, the platform aims to reduce dropout rates and accelerate trial completion.

Evrima provides a technology-driven platform that enhances the recruitment process for clinical trials by efficiently connecting diverse participants with researchers and clinicians. This approach addresses the significant delays in trial recruitment, enabling faster patient enrollment and improved health outcomes.

Limmi is a data analysis platform that automates the import and cleaning of clinical data, enabling researchers to analyze multi-modal datasets using over 60 statistical models. By streamlining data preparation, Limmi reduces the time from data collection to actionable insights, facilitating faster drug and biomarker discovery.

ReadoutAI automates the analysis of clinical trial data through AI-driven workflows that include data cleaning, statistical analysis, and report generation. This technology reduces the time required for these tasks by up to 85%, enabling faster insights and more efficient trial management.

The startup operates an online medical platform that enhances community engagement in clinical trial education and patient recruitment through targeted outreach and support for nonprofit organizations. By increasing enrollment in clinical trials, the platform enables diverse participation in medical studies, ultimately improving healthcare outcomes.

The startup provides clinical trial and therapy services that enhance patient engagement and optimize trial processes for pharmaceutical companies. By improving the quality of patient data and fostering trust in trial partnerships, the company addresses inefficiencies in clinical research and patient recruitment.

Aparito's Atom5™ eCOA platform digitizes clinical trials by capturing high-frequency data through video assessments, wearable devices, and electronic patient-reported outcomes (ePROs). This technology enables clinical teams to obtain real-time insights from real-world data, enhancing the efficiency and accuracy of trial monitoring.

Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.

GeneHub is a clinical trials accelerator that connects patients with drug developers to enhance access to relevant medications. The platform streamlines patient recruitment and data collection, addressing the inefficiencies in clinical trial processes that delay drug availability.

AutoCruitment has developed an automated platform that utilizes online behavior tracking and geotargeting to directly recruit, screen, and refer patients for clinical trials, eliminating the need for provider approval and medical record access. This technology addresses the challenge of slow patient enrollment in clinical studies by increasing the speed and efficiency of patient recruitment, resulting in a 97% increase in randomizations across over 700 completed trials.

Infiuss operates a blood bank that facilitates emergency blood donation campaigns and provides essential healthcare services. The platform addresses the critical shortage of blood supply by connecting donors with healthcare facilities in need of immediate blood resources.

tenac provides the OptiCor digital health platform to support cardiovascular disease management for physicians and patients. The platform uses a validated algorithm to generate individual risk assessments for mortality, stroke, and bleeding based on clinical data. This enables the delivery of guideline-based, optimized treatment recommendations intended to lower adverse events and healthcare costs.

Stemnovate develops multi-organ modeling platforms for drug discovery, utilizing in vitro cell culture and digital karyotyping to assess drug metabolism and toxicity. The company addresses the need for safer clinical trials and improved patient outcomes, particularly for rare diseases in children.

The startup provides clinical trial matching services that utilize patient outreach, physician referrals, and pre-screening programs to enhance the recruitment process for oncology trials. By increasing the accuracy and efficiency of patient enrollments, the company addresses the challenge of low participation rates in clinical studies, benefiting investigators and trial sponsors alike.

Healp provides a platform for managing and tracking healthcare service requests and patient needs. The system streamlines communication between patients, providers, and administrative staff to ensure timely care coordination. This results in optimized resource allocation and improved operational efficiency within healthcare settings.

QMENTA provides an integrated imaging platform designed to streamline workflows for clinical trials, research, and care providers. The system incorporates tools like automated PHI de-identification, secure cloud PACS integration, and over 50 AI imaging biomarkers. This unified infrastructure aims to accelerate decision-making, reduce operational costs, and enhance the accuracy of medical imaging analysis.

Medibanx provides longitudinal clinical data obtained with patient consent to accelerate drug development timelines. By offering access to comprehensive patient data, the company addresses the inefficiencies in clinical trials and regulatory processes.

Cytocast develops AI-powered simulation platforms to predict and mitigate drug side-effect liabilities throughout the discovery and preclinical development pipeline. Their suite of products—Screener, Optimizer, and Nominator—uses digital twin technology to analyze molecular interactions within simulated human cells. This capability allows pharmaceutical researchers to fail candidates earlier, refine selections based on adverse event profiles, and de-risk lead nomination before costly clinical trials.

Cogniant is an AI-assisted digital health platform that passively collects digital biomarkers from diverse patient populations to enhance the efficacy of clinical trials for neurological and psychiatric disorders. By providing real-time data for expansive phenotyping and clinical state prediction, Cogniant bridges the gap between clinical trial outcomes and real-world effectiveness.

Kapsule provides a secure, compliant health-data infrastructure across Africa, offering access to millions of anonymized patient records and facility intelligence. This platform accelerates pharmaceutical research, clinical trial site matching, and resource allocation decisions for global health organizations. The service enables data partners to generate revenue through transparent, shared-value data monetization models.